Brain Malformation
7
3
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
AIRFRAME: Artificial Intelligence for Recognition of Fetal bRain AnoMaliEs at Second Trimester Fetal Brain Scan
The Role of CSF in Chiari II Brain Malformation
Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
Human Epilepsy Genetics--Neuronal Migration Disorders Study
Protecting Brains and Saving Futures - the PBSF Protocol
Comparison of Abnormal Cortical Development in Brain Malformations on Postmortem Imaging With Autopsy